-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

704. Cellular Immunotherapies: Clinical: Poster II

Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 12, 2021: 6:00 PM-8:00 PM
Hall B5, Level 1, Building B (Georgia World Congress Center)

Lia Minculescu, MD, PhD1*, Joanne Reekie2*, Søren Lykke Petersen, MD, DMSc3*, Brian Thomas Kornblit, MD, PhD3*, Ida Schjødt, MD, PhD3*, Niels Smedegaard Andersen, MD, DMSc3*, Lisbeth Pernille Andersen, MD1*, Anne Fischer-Nielsen, MD, PhD1,4*, Eva Kannik Hastrup, MD, PhD1*, Lone Smidstrup Friis, MD, PhD3* and Henrik Sengeloev, MD, DMSc, Prof3*

1Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
2Department of Infectious Diseases, PERSIMUNE, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
3Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
4Department of Quality, StemMedical A/S, Soeborg, Copenhagen, Soeborg, Denmark

Ying Wang, MD1, Xiaojuan Chen, MD2*, Shuning Wei1*, Yingchang Mi, MD3, Lin Shi, PhD4*, Ying Wang4*, Yongzeng Wang, PhD4*, Changting Haudenschild, PhD4*, Lulu Lv, PhD5*, Xiaofan Zhu, MD6 and Jianxiang Wang, MD7

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
2Division of Pediatric Blood Disease Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
3Leukemia center, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
4Juventas Cell Therapy Ltd, Tianjin, China
5Juventas Cell Therapy Ltd., Tianjin, China
6Division of Pediatric Blood Diseases Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China, Tianjin, China
7State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Sandy W. Wong, MD1, Shambavi Richard2*, Yi Lin3, Deepu Madduri4*, Carolyn C. Jackson4*, Enrique Zudaire5*, Vadim Romanov6, Michael Trigg6*, Martin Vogel7*, Ashraf Garrett8*, Lisa Hullinger8*, Tonia Nesheiwat8*, Thomas Martin, MD1 and Sundar Jagannath, MD2*

1UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
2Mount Sinai Medical Center, New York, NY
3Mayo Clinic, Rochester, MN
4Janssen R&D, Raritan, NJ
5Janssen R&D, Spring House, PA
6Janssen Biotech Inc, Horsham, PA
7Janssen Global Services, LLC., Raritan, NJ
8Legend Biotech USA, Piscataway, NJ

JIA Wei, MD, PhD1*, Liang Huang, MD2, Lili Gao3*, Min Xiao, M.D. Ph.D.4* and Jianfeng Zhou, MD, PhD2*

1Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, BALTIMORE, MD
2Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
4Department of Hematology,Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Matthew J. Frigault, MD1, Kathleen M.E. Gallagher, PhD2*, Marc Wehrli, MD, PhD3*, Betsy Valles4*, Keagan Casey, BS4*, Kevin Lindell, BS4*, Michael Trailor, BS4*, Hana Cho4*, Jami L. Brown, MS5*, Nora K. Horick, MS6*, Justin Chou7*, Rhine R. Shen, PhD7*, Simone Filosto, PhD7*, Adrian Bot, MD, PhD7* and Marcela V. Maus, MD4

1Department of Medicine, Massachusetts General Hospital, Boston, MA
2Massachusetts General Hospital, Harvard Medical School, Charlestown, MA
3Massachusetts General Hospital, Charlestown, MA
4Cancer Center, Massachusetts General Hospital, Boston, MA
5Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA
6Harvard Medical School, Boston, MA
7Kite, a Gilead Company, Santa Monica, CA

Cameron J. Turtle, MBBS, PhD1,2, Elizabeth Budde, MD, PhD3, Krina K. Patel, MD, MSc4, Miguel-Angel Perales, MD5, Andrew J. Cowan, MD1,6, Hayder Saeed, MD7, Julio C. Chavez, MD, MS7, Alexandre V. Hirayama, MD6, Delaney R. Kirchmeier, BSc6*, Murali Janakiram, MD, MS8*, Kai Wu, MD, PhD9*, Lawrence Fong, MD9*, Zachary Lee, PharmD10*, Neha Dixit, PhD10*, Xiaoli Wang, PhD, MBA10*, Kazuharu Kai, MD, PhD10*, Mario Q. Marcondes, MD, PhD10, Jonathan Zalevsky, PhD10* and Nina Shah, MD9

1University of Washington, Seattle, WA
2Fred Hutchinson Cancer Research Ctr., Seattle, WA
3City of Hope National Medical Center, Duarte, CA
4MD Anderson Cancer Center, University of Texas, Houston, TX
5Memorial Sloan-Kettering Cancer Center, New York, NY
6Fred Hutchinson Cancer Research Center, Seattle, WA
7H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
8University of Minnesota, Minneapolis, MN
9University of California San Francisco, San Francisco, CA
10Nektar Therapeutics, San Francisco, CA

Nicolas Gazeau1*, Pere Barba, MD, PhD2*, Gloria Iacoboni, MD3,4*, Mi Kwon, MD, PhD5,6*, Rebeca Bailen7,8*, Juan Luis Reguera9*, Lucía López Corral, MD10*, Rafael Hernani, MD11*, Valentín Ortiz-Maldonado, MD, PhD12*, Antonio Perez-Martinez, MD, PhD13*, Richard T. Maziarz, MD14, Staci Williamson, MS14*, Eneida R. Nemecek, MD, MBA, MSc15, Mazyar Shadman, MD16, Andrew Coman17*, Damian J. Green, MD18, Victor A. Chow, MD19, Alexandre V. Hirayama, MD18, David G. Maloney, MD, PhD20, Cameron J. Turtle, MBBS, PhD21 and Jordan Gauthier, MD19,21,22

1Clinical Research Division, Fred Hutchinson Cancer Research center, Seattle, WA
2Hospital Universitari Vall d’Hebron and Universitat Autonoma de Barcelona, Barcelona, Spain
3Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
4Vall d’Hebron University Hospital, Barcelona, Spain
5Hematology Department, Gregorio Marañón General University Hospital, Madrid, Spain
6Department of Hematology, Hospital General Universitario Gregorio Marañón, Gregorio Marañon Health Research Institute, Madrid, Spain
7Hospital General Universitario Gregorio Marañón, Gregorio Marañon Health Research Institute, Madrid, Spain
8Department of Hematology, Gregorio Marañón General University Hospital, Madrid, Spain
9Hospital Universitario Virgen del Rocío, Sevilla, Spain
10Hematology Department, Hospital Clínico Universitario de Salamanca (CAUSA/IBSAL), Salamanca, Spain
11Department of Hematology, Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain
12Department of Hematology, Hospital Clinic de Barcelona, Barcelona, Spain
13Department of Hematologia-Oncologia, Hospital Universitario La Paz, Madrid, Spain
14Knight Cancer Institute, Oregon Health and Science University, Portland, OR
15Pediatric Hematology/Oncology & Bone Marrow Transplantation, Oregon Health & Science University, Knight Cancer Institute Doernbecher Children's Hospital, Portland, OR
16University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA
17Department of Medicine, University of Washington, Seattle, WA
18Fred Hutchinson Cancer Research Center, Seattle, WA
19Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
20Fred Hutchinson Cancer Rsrch. Ctr., Seattle, WA
21Clinical Research Division, Fred Hutchinson Cancer Research Ctr., Seattle, WA
22University of Washington, Seattle Cancer Care Alliance, Seattle, WA

Ahmad-Samer Al-Homsi, MD1, Sebastien Anguille2*, Dries Deeren, MD3, Taiga Nishihori, MD4, Nathalie Meuleman, PhD, MD5*, Maher Abdul-Hay, MD1*, Gareth J. Morgan1*, Jason Brayer, PhD, MD4, Nathalie Braun6*, Caroline Lonez, PhD6*, Marie-Sophie Dheur, PhD, PharmD6*, Erik Alcantar-Orozco, MD6*, David Gilham, PhD6, Anne Flament, MD6* and Frédéric F. Lehmann, MD6*

1New York University Langone Health, New York, NY
2Antwerp University Hospital, Antwerp, Belgium
3Algemeen Ziekenhuis (AZ) Delta, Roeselare, Belgium
4H. Lee Moffitt Cancer Center, Tampa, FL
5Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
6Celyad Oncology, Mont-Saint-Guibert, Belgium

Anne Mea Spanjaart, MD1*, Per Ljungman, MD, PhD2, Rafael De La Camara, MD3, Gloria Tridello4*, Valentín Ortiz-Maldonado, MD, PhD5*, Alvaro Urbano-Ispizua, MD, PhD5, Pere Barba, MD, PhD6*, Mi Kwon, MD, PhD7*, Dolores Caballero, MD8, Pierre Sesques, MD9*, Emmanuel Bachy, MD, PhD10*, Roberta Di Blasi, MD, PhD11*, Catherine Thieblemont, MD, PhD11, Friso Calkoen12*, Pim G.N.J. Mutsaers, MD, PhD13*, Johan A. Maertens, MD, PhD14*, Livia Giannoni, MD15*, Emma Nicholson, MD, PhD16*, Matthew P. Collin, MD, PhD17, Carlos Pinho Vaz, MD18*, Elisabetta Metafuni19*, Joaquín Martínez-López20*, Fiona Dignan, MD, FRCP, FRCPath21*, Josep-Maria Ribera, MD, PhD22, Arnon Nagler, M.D.23, František Folber, MD, PhD24*, Robin Sanderson, PhD25, Adrian Bloor, MD, PhD, FRCP, FRCPath26*, Fabio Ciceri, MD27*, Nina Knelange28*, Francis A. Ayuk, MD29*, Nicolaus Kröger, MD29*, Marie José Kersten, MD, PhD30 and Stephan Mielke, MD31

1Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam and LYMMCARE, Amsterdam, Netherlands
2Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden
3Department of Hematology, Hospital Universitario de La Princesa, Madrid, Spain
4Pediatric Hematology Oncology, Azienda Ospedaliera Universitaria Integrata, Verona, Italy
5Department of Hematology, Hospital Clinic de Barcelona, Barcelona, Spain
6Department of Hematology, Vall d’Hebron University Hospital, University Hospital Vall d’Hebron, Barcelona, Spain
7Department of Hematology, Hospital General Universitario Gregorio Marañón, Gregorio Marañon Health Research Institute, Madrid, Spain
8Department of Hematology, Hospital Universitario de Salamanca (HUS/IBSAL) and CIBERONC, Salamanca, Spain
9Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Benite, France
10Department of Hematology, Lyon Sud Hospital, Lyon, France
11Department of Hematology, Assistance Publique Hôpitaux de Paris - Hopital Saint-Louis, University of Paris, Paris, France
12Princess Maxima Centre for Pediatric Oncology, Utrecht, Netherlands
13Department of Hematology, Erasmus MC Cancer Center, Rotterdam, Netherlands
14Deptartment of Hematology, University Hospital Gasthuisberg, University of Leuven, Leuven, Belgium
15Ematologia e Centro Trapianti, IRCCS Ospedale Policlinico San Martino, Genova, Italy
16Department of Hematology, The Royal Marsden Hospital, University College London, London, GBR
17Adult HSCT unit, Northern Centre for Bone Marrow Transplantation, Newcastle Upon Tyne, United Kingdom
18BMT Unit, Instituto Português de Oncologia do Porto, Porto, Portugal
19Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione policlinico gemelli IRCSS, Rome, Italy
20Department of Hematology, Hospital Univ. 12 de Octubre, Complutense University, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain
21Clinical Haematology Department, Manchester Royal Infirmary, Manchester, GBR
22Clinical Hematology Department, Ico-Hospital Universitari Germans Trias Y Pujol, Badalona, Barcelona, Spain
23Division of Hematology, Chaim Sheba Medical Center, Tel Hashomer, Israel
24Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
25Department of Haematological Medicine, Barts Cancer Institute, London, Eng, United Kingdom
26Adult Leukaemia and Bone Marrow Transplant Unit, The Christie Hospital NHS Foundation Trust, University of Manchester, Manchester, United Kingdom
27Haematology and BMT, Ospedale San Raffaele s.r.l., Milano, Italy
28EBMT Data Office, Leiden, Netherlands
29Department of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Hamburg, Germany
30Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands and LYMMCARE, Amsterdam, Netherlands
31Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Dept. of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden

Carlos A. Ramos, MD1, Amy N. Courtney, PhD2*, Simon N. Robinson, PhD2*, Olga Dakhova, PhD3*, Premal D. Lulla, MBBS1, Rammurti Kamble, MD1, George Carrum, MD1, Tao Wang, PhD4*, Chunchao Zhang, PhD2*, Erica Di Pierro, PhD2* and Leonid S. Metelitsa, MD, PhD1,2*

1Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Texas Children's Hospital, Houston, TX
2Center for Advanced Innate Cell Therapy, Texas Children's Cancer and Hematology Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX
3Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX
4Biostatistics and Informatics Shared Resource, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX

Xian Zhang1,2, Gailing Zhang, MD.2*, Wenqian Li2*, Liyuan Qiu2*, Dongchu Wang2*, Junfang Yang1,2*, Jingjing Li1,2* and Peihua Lu, MD1,2,3

1Beijing Lu Daopei Institute of Hematology, Beijing, China
2Hebei Yanda Lu Daopei Hospital, Langfang, China
3Department of Oncology, Capital Medical University, Beijing, China

Wenming Chen, MD, PhD1*, Chengcheng Fu, MD, PhD2*, Zhen Cai, PhD, MD3*, Zonghai Li, MD, PhD4*, Huijuan Wang1*, Lingzhi Yan, MD, PhD2*, Yin Wu, MD, PhD1*, Xiaolan Shi, MD, PhD2*, Wen Gao, MD1, Shuang Yan, MD2*, Wei Wang, MD, PhD4*, Xiaoyan Han3*, Gaofeng Zheng3*, Yanling Wen, MD3*, Jun Xiao, MD4*, Huamao Wang, PhD4* and Xiaole Tang4*

1Beijing Chao-Yang Hospital of Capital Medical University, Beijing, China
2The First Affiliated Hospital of Soochow University, Suzhou, China
3The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
4CARsgen Therapeutics Co. Ltd, Shanghai, China

Liana Nikolaenko, MD1, Carolyn Mulroney, MD2, Peter A. Riedell, MD3, Ian W. Flinn, MD, PhD4, Jose Carlos Cruz, MD5, Rakhee Vaidya, MD6, Koen Van Besien, MD, PhD7, Michael Emde8*, Vadim Klyushnichenko, PhD9*, Jonathan Strauss, MS9*, Eduardo Laborda, DVM, PhD10*, Jing Li, PhD8*, Mohit Trikha, PhD11*, Peter G. Schultz, PhD12* and Travis S Young, PhD9*

1Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
2UCSD Moores Cancer Center, La Jolla, CA
3Section of Hematology/Oncology, University of Chicago, Chicago, IL
4Sarah Cannon Research Institute-Tennessee Oncology, Nashville, TN
5Adult Blood & Marrow Stem Cell Transplant, Texas Transplant Physician Group, San Antonio, TX
6Comprehensive Cancer Center of Wake Forest Baptist Health, Winston-Salem, NC
7Presbyterian/Weill Cornell Medical College, New York, NY
8Calibr, a Division of Scripps Research, The Scripps Research Institute, La Jolla, CA
9Calibr, a Division of Scripps Research, La Jolla, CA
10Calibr, The Scripps Research Institute, La Jolla, CA
11Abbvie, Redwood City, CA
12The Scripps Research Institute, San Diego, CA

Moazzam Shahzad, MD1,2*, Muhammad Salman Faisal, MD3, Ernie Shippey4*, Ali Hussain, MD2*, Clint Divine, MBA, MSM2*, Zahra Mahmoudjafari, PhD2*, Allison Appenfeller2*, Muhammad Umair Mushtaq, MD2, Leyla Shune, MD2, Joseph P. McGuirk, DO5 and Nausheen Ahmed, MBBS2

1Internal Medicine, St. Mary's Medical Center, Huntington, WV
2Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
3Roswell Park Cancer Center, Buffalo, NY
4Vizient CBD, Irving, TX
5Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Westwoon, KS

Robert D Knight, MD1*, Myo Htut2, Juan C. Varela, MD, PhD3,4, Andrew Kin, MD5, Vineetha Edavana, PhD6*, Emily Lu, PhD7*, Sojung Kim, PhD7*, Lauren Suarez, PhD6*, Mathias Oelke, PhD7* and Daniel Bednarik, PhD6*

1Neximmune, Inc, Berkeley Heights, NJ
2Comprehensive Cancer Center, City of Hope National Medical Center, Duarte, CA
3Blood and Marrow Transplant Center, Florida Hospital, WINTER PARK, FL
4Blood and Marrow Transplant Program, Advent Health, Orlando, FL
5Department of Oncology, Blood and Marrow Stem Cell Transplant Program, Karmanos Cancer Institute/ Wayne State University, Detroit, MI
6NexImmune, Inc, Gaithersburg, MD
7Neximmune Inc, Gaithersberg, MD

Shafqat Inam, MBBS, FRACP, FRCPA1*, Gaurav Sutrave, BSc (Med), MBBS, FRACP, FRCPA2*, Selmir Avdic, PhD2*, Janine Street, BSc MSc (Hons)2*, Elissa Atkins, RN1*, Leighton Edward Clancy, BSc, PhD3* and David J Gottlieb, MD, MBBS, FRACP, FRCPA4,5*

1Department of Haematology, Westmead Hospital, Westmead, NSW, Australia
2Westmead Institute for Medical Research, The University of Sydney, Sydney, Australia
3Westmead Hospital, Sydney Cellular Therapies Laboratory, Sydney, Australia
4Department of Haematology, Westmead Hospital, Sydney, Australia
5Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia

Andrew Lytle, MD1, Sophia Faude2*, Jason Xu2* and Vinodh Pillai, MD, PhD3,4

1Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Vancouver, BC, Canada
2Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
3Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
4Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA

Gloria Iacoboni, MD1*, Kai Rejeski, MD2, Lina Camacho3,4,5*, Annalisa Chiappella, MD6, Serafina Guadagnuolo7*, Lucía López Corral, MD8*, Mariana Bastos-Oreiro, MD, PhD9*, Javier Delgado Serrano, MD10*, Christian Schmidt, MD2*, Cecilia Carpio, MD1*, Juan Luis Reguera10*, Mi Kwon9*, Alejandro Martín García-Sancho8*, Pier Luigi Zinzani, MD, PhD7, Paolo Corradini, Prof11*, Marion Subklewe, MD12 and Pere Barba, MD, PhD1*

1Vall d’Hebron University Hospital, Barcelona, Spain
2Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
3Department of Pharmacology, Therapeutics and Toxicology, Autonomous University of Barcelona, Barcelona, Spain
4Clinical Pharmacology Department, Vall d’Hebron University Hospital, Barcelona, Spain
5Clinical Pharmacology, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain
6Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
7Institute of Hematology "L. e A. Seràgnoli," University of Bologna, Bologna, Italy
8Hospital Clínico Universitario de Salamanca, Salamanca, Spain
9Gregorio Marañon General University Hospital, Madrid, Spain
10Hospital Universitario Virgen del Rocío, Sevilla, Spain
11Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
12Department of Medicine III, University Hospital, LMU Munich, Muenchen, Germany

Hannah Kinoshita1*, Kenneth R. Cooke, MD2, Melanie Grant, PhD3*, Maja Stanojevic, MD4*, Conrad Russell Young Cruz, MD, PhD4,5, Michael Keller, MD4,5*, Maria Fernanda Fortiz, BA4*, Fahmida Hoq, MD4*, Haili Lang, MS4*, John Barrett, MD6*, Hua Liang, PhD7*, Jay Tanna, MS4*, Nan Zhang4*, Abeer Shibli, BS4*, Anushree Datar4*, Kirsten M. Williams, MD8, Hema Dave, MD4*, Jeffrey Dome, MD4,5*, David Jacobsohn, MD5,9*, Patrick Hanley, PhD4,5*, Richard J. Jones, MD2 and Catherine M. Bollard, MD, MBChB5,10

1Center for Cancer and Immunology Research, Children’s National Research Institute, Children's National Health System, Washington, DC
2Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
3Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
4Center for Cancer and Immunology Research, Children’s National Research Institute, Children's National Hospital, Washington, DC
5Department of Pediatrics, The George Washington University, Washington, DC
6Stem cell Transplantation and Cell Therapy Program, George Washington Cancer Center, Washington, DC
7The George Washington University, Washington, DC
8Children's Healthcare of Atlanta, Aflac Cancer and Blood Disorders, Emory University, Atlanta, GA
9Center for Cancer and Immunology Research, Children’s National Research Institute, Children’s National Hospital, Washington, DC
10Center for Cancer and Immunology Research, Children’s National Research Institute, Children's National Medical Center, Washington, DC

George E. Hucks Jr., MD1*, Barbara Savoldo, MD, PhD1*, Gianpietro Dotti, MD1*, Catherine Joyce Arago Cheng, BS1*, Caroline Babinec, BA1*, Kimberly A. Kasow, DO1*, Michael Winstead, MD1*, Arpita Patel1*, Cammie Presler1*, Natalie S Grover, MD1, J. Kaitlin Morrison, PhD1*, Anne W. Beaven, MD1, Marcie L. Riches, MD2, Thomas C. Shea, MD1 and Jonathan S. Serody, MD1

1Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
2Division Hematology/Oncology, University of North Carolina, Chapel Hill, NC

Jessica J. Liegel, MD1, Poorva Bindal, MD1, Richard M. Stone, MD2, Robert J. Soiffer, MD2, Dina Stroopinsky1*, Giulia Cheloni, PhD1*, Lina Bisharat3*, Daniela Torres3*, Maryam Rahimian, MD3*, Seo Yeon Yoo3*, Emma K. Logan3*, Pavania Elavalakanar3*, Hassan El Banna4*, Joshua Hauser3*, Anita G. Koshy1*, Rizwan Romee, MD2, Vincent T. Ho, MD2*, Donna S. Neuberg, ScD5, Yiwen Liu6*, Lourdes M. Mendez, MD, PhD1, Ajoy L. Dias, MD1, Benjamin L. Ebert, MD2, Donald Kufe, MD2*, David Avigan, MD1 and Jacalyn Rosenblatt, MD3

1Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
2Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
3Beth Israel Deaconess Medical Center, Boston, MA
4Dana-Farber Cancer Institute, Boston, MA
5Data Science, Dana-Farber Cancer Institute, Boston, MA
6Department of Data Science, Dana-Farber Cancer Institute, Boston, MA

Yingnan Li1,2,3*, Heng Mei2,3,4*, Mengyi Du1,5*, Chenggong Li2,3*, Yinqiang Zhang2,3*, Wenjing Luo2,3*, Haiming Kou2,6* and Yu Hu2,3*

1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China, Wuhan, China
2Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China
4Union Hospital of Tongji Medical College; Huazhong University of Science and Technology, Wuhan, China
5Hubei clinical medical center of cell therapy for neoplastic disease, Wuhan, 430022, China, Wuhan, China
6Hubei clinical medical center of cell therapy for neoplastic disease, Wuhan, China

Olalekan O. Oluwole, MBBS, MPH1, Edouard Forcade, MD, PhD2*, Javier Muñoz, MD, MS, MBA, FACP3, Sophie de Guibert, MD4*, Julie M. Vose, MD, MBA5, Nancy L. Bartlett, MD6, Yi Lin7, Abhinav Deol8, Peter A. McSweeney, MD ChB9*, Andre H. Goy, MD10*, Marie José Kersten, MD, PhD11,12, Caron Jacobson, MD13, Umar Farooq, MD14, Monique C. Minnema, MD15,16, Catherine Thieblemont, MD, PhD17, John M. Timmerman, MD18, Patrick Stiff, MD19, Irit Avivi, MD20,21*, Dimitrios Tzachanis, MD, PhD22*, Jenny J. Kim, MD, MS23*, Yan Zheng, MS23*, Rhine R. Shen, PhD23*, Saran Vardhanabhuti, PhD23* and Tom Van Meerten24,25*

1Vanderbilt-Ingram Cancer Center, Nashville, TN
2CHU Bordeaux, Bordeaux, France
3Banner MD Anderson Cancer Center, Gilbert, AZ
4Hématologie Clinique, CHU Rennes, Rennes, France
5University of Nebraska Medical Center, Omaha, NE
6Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
7Mayo Clinic, Rochester, MN
8Karmanos Cancer Institute, Wayne State University, Detroit, MI
9Colorado Blood Cancer Institute, Denver, CO
10Hackensack University Medical Center, John Theurer Cancer Center, Hackensack, NJ
11Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
12on behalf of HOVON/LLPC (Lunenburg Lymphoma Phase I/II Consortium), Amsterdam, Netherlands
13Dana-Farber Cancer Institute, Boston, MA
14University of Iowa, Iowa City, IA
15on behalf of HOVON/LLPC (Lunenburg Lymphoma Phase I/II Consortium), Utrecht, Netherlands
16University Medical Center Utrecht, Utrecht, Netherlands
17Hemato-Oncology Department, APHP, Saint-Louis Hospital, Paris, France
18UCLA David Geffen School of Medicine, Los Angeles, CA
19Loyola University Chicago Stritch School of Medicine, Maywood, IL
20The Sackler Faculty of Medicine, Tel-Aviv University, Ramat Aviv, Tel Aviv, Israel, Tel Aviv, Israel
21Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
22Moores Cancer Center, University of California San Diego, La Jolla, CA
23Kite, a Gilead Company, Santa Monica, CA
24on behalf of HOVON/LLPC (Lunenburg Lymphoma Phase I/II Consortium), Groningen, Netherlands
25Department of Hematology, University Medical Center Groningen, Washington, DC

Qinghua Song, PhD1*, Tao Hu, PhD1*, Sattva S. Neelapu, MD2, Frederick L. Locke, MD3, Caron Jacobson, MD4, David B. Miklos, MD, PhD5, Olalekan O. Oluwole, MBBS, MPH6, Marie José Kersten, MD, PhD7,8, Max Topp9, Jenny J. Kim, MD, MS1*, Kanwarjit Singh, MD1*, Jorge Andrade, PhD1*, Lei Huang, PhD1*, Allen Xue, PhD1*, Marco Schupp, MD1*, Myrna Nahas, MD1*, Rhine R. Shen, PhD1* and Adrian Bot, MD, PhD1*

1Kite, a Gilead Company, Santa Monica, CA
2The University of Texas MD Anderson Cancer Center, Houston, TX
3Moffitt Cancer Center, Tampa, FL
4Dana-Farber Cancer Institute, Boston, MA
5Stanford University School of Medicine, Stanford, CA
6Vanderbilt-Ingram Cancer Center, Nashville, TN
7on behalf of HOVON/LLPC (Lunenburg Lymphoma Phase I/II Consortium), Amsterdam, Netherlands
8University of Amsterdam, Amsterdam UMC, Amsterdam, Netherlands
9Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany

Sattva S. Neelapu, MD1, Mehdi Hamadani, MD2, Don Stevens, MD3, Sandra M. Hayes, PhD4*, Francesco Galimi, MD, PhD5 and David B. Miklos, MD, PhD6

1Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center, Houston, TX
2BMT & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, WI
3Norton Healthcare, Norton Cancer Institute, Louisville, KY
4Adicet Bio, Menlo Park, CA
5Adicet Bio, Menlo park, CA
6Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University Hospital, Stanford, CA

Michel Delforge1, Nina Shah, MD2, Paula Rodríguez-Otero, MD, PhD3*, Julia Braverman, PhD4*, Devender Dhanda4*, Ling Shi, PhD5*, Shien Guo, PhD5*, Peiwen Yu6*, Weiqin Liao6*, Timothy B. Campbell, MD, PhD4* and Nikhil C. Munshi, MD, PhD7

1University Hospital Leuven, Leuven, Belgium
2University of California San Francisco, San Francisco, CA
3Clínica Universidad de Navarra, Pamplona, Spain
4Bristol Myers Squibb, Princeton, NJ
5Clinical Outcomes Assessment, Evidera, Waltham, MA
6Evidera, Waltham, MA
7The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Tanya Siddiqi, MD1, Xiuli Wang, PhD2, M. Suzette Blanchard3*, Jamie Wagner, BS4*, Vibhuti Vyas, MS5*, Mary C. Clark, PhD6*, Sandra Thomas, PhD7, Baishakhi Barva7*, Angelica Gamez7*, Leslie L. Popplewell, MD, FACP8, Alex F. Herrera, MD7, Elizabeth Budde, MD, PhD9, Liana Nikolaenko, MD1, Christine E Brown, PhD10* and Stephen J Forman, MD11

1Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
2Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Beckman Research Institute, Duarte, CA
3City of Hope/Beckman Research Institute, Duarte, CA
4T Cell Therapeutics Laboratory, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
5City of Hope, Duarte
6Department of Clinical and Translational Project Development, City of Hope, Duarte, CA
7City of Hope, Duarte, CA
8Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
9T Cell Therapeutics Research Laboratory, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
10T-Cell Therapeutics Research Laboratory, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
11Department of Hematology/HCT, City of Hope, Beckman Research Institute, Duarte, CA

Carlos Fernandez de Larrea, MD, PhD1, Veronica Gonzalez-Calle, MD, PhD2*, Valentin Cabañas, MD3*, Aina Oliver-Caldes, MD1*, Marta Español-Rego4*, Paula Rodriguez-Otero5*, Juan Luis Reguera6*, Lucía López Corral, MD2*, Susana Inogés, MD, PhD5*, Beatriz Martin-Antonio, PhD1,7*, Bruno Paiva, PhD5*, Laura Rosinol8*, Ascensión López-Diaz de Cerio, PhD5*, Natalia Tovar1*, Miriam Lopez Parra2*, Luis Gerardo Rodríguez-Lobato1*, Sara Varea1*, Andres Sanchez Salinas3*, Valentín Ortiz-Maldonado, MD, PhD1*, Jose A. Perez-Simon, MD, PhD9, Felipe Prósper, MD, PhD5*, Manel Juan, MD1*, Jose Maria Moraleda, MD, PhD3*, Maria-Victoria Mateos2, Mariona Pascal1* and Álvaro Urbano-Ispizua, MD, PhD1*

1Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona, Barcelona, Spain
2Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Salamanca, Spain
3Hospital Clínico Universitario Virgen de la Arrixaca. IMIB-Arrixaca. University of Murcia, Murcia, Spain
4Department of Immunology, IDIBAPS, Hospital Clínic de Barcelona, Barcelona, Spain
5Clínica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), IDISNA, CIBERONC Pamplona, Pamplona, Spain
6Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC/CIBERONC), University of Sevilla, Sevilla, Spain
7Instituto de Investigación Sanitaria-Fundación Jimenez Diaz, Madrid, Spain
8Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain
9Instituto de Biomedicina de Sevilla (IBiS), UGC-Hematología, Hospital Universitario Virgen del Rocío/ CSIC/ CIBERONC, Universidad de Sevilla, Sevilla, Spain

Binod Dhakal, MBBS1, Tania Felizardo, PhD2*, Lawrence G. Lum, MD3, Anita D'Souza, MD4*, Saurabh Chhabra, MD, MS5, Taylor Keaton6*, Meera Mohan, MD, MS1*, Jee H Park7*, Daniel H Fowler, MD7* and Parameswaran Hari8

1Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
2Rapa Therapeutics, Rockland, MD
3Barbara Ann Karmanos Cancer Institute, Charlottesville, VA
4Malignant Hematology and BMT, Froedtert and Medical College of Wisconsin Cancer Center, Wauwatosa, WI
5Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
6Medical College of Wisconsin, Milwaukee
7Rapa Therapeutics, Rockville, MD
8Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI

Jared McFerran1,2*, Andrew Lytle, MD3, Kirubel Gebre4* and Vinodh Pillai, MD, PhD5,6

1University of Pennsylvania, Ambler, PA
2University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
3Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Vancouver, BC, Canada
4University of Pennsylvania Perelman School of Medicine, Lancaster, PA
5Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
6Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA

Jeremy S. Abramson, MD1, M. Lia Palomba, MD2, Leo I. Gordon, MD3, Matthew A. Lunning, DO, FACP4, Michael Wang, MD5, Jon E. Arnason, MD6, Enkhtsetseg Purev, MD, PhD7*, David G. Maloney, MD, PhD8, Charalambos Andreadis, MD, MS9, Alison R. Sehgal, MD10, Scott R. Solomon, MD11, Nilanjan Ghosh, MD, PhD12, Ana Kostic, MD13*, Yeonhee Kim, PhD13*, Ken Ogasawara, PhD, MPH14*, Christine Dehner, BSc13* and Tanya Siddiqi, MD15

1Massachusetts General Hospital Cancer Center, Boston, MA
2Memorial Sloan Kettering Cancer Center, New York, NY
3Northwestern University, Robert H Lurie Comprehensive Cancer Center, Chicago, IL
4University of Nebraska Medical Center, Omaha, NE
5University of Texas MD Anderson Cancer Center, Houston, TX
6Beth Israel Deaconess Medical Center, Boston, MA
7University of Colorado School of Medicine, Aurora, CO
8Fred Hutchinson Cancer Research Center, Seattle, WA
9Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA
10University of Pittsburgh School of Medicine, UPMC Hillman Cancer Center, Pittsburgh, PA
11Transplant and Cellular Immunotherapy Program, Northside Hospital Cancer Institute, Atlanta, GA
12Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
13Bristol Myers Squibb, Seattle, WA
14Bristol Myers Squibb, Princeton, NJ
15City of Hope National Medical Center, Duarte, CA

Omar H Butt, MD, PhD, MS1*, Alice Y. Zhou, MD, PhD2*, Paolo F. Caimi, MD3, Paul-Robert Derenoncour, MD4*, Kenneth Lee, BS5*, Gregory F Wu, MD, PhD5*, Marcos J.G. de Lima, MD6, John F. DiPersio, MD, PhD7, Jian L. Campian, MD, PhD1*, Armin Ghobadi, MD8,9 and Beau M Ances, MD, PHD5*

1Siteman Cancer Center, Washington University in Saint Louis, Saint Louis, MO
2Department of Medicine, Washington University School of Medicine, St. Louis, MO
3University Hospitals of Cleveland, Cleveland, OH
4Mallinckrodt Institute of Radiology, Division of Nuclear Medicine, Washington University in Saint Louis, SAINT LOUIS, MO
5Department of Neurology, Washington University in Saint Louis, Saint Louis, MO
6Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH
7Division of Oncology, Washington University School of Medicine, Saint Louis, MO
8BMT and Leukemia Program, Department of Medicine, Washington University School of Medicine, Saint Louis, MO
9Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO

Yue Huang, MD1*, Houli Zhao, MD2*, Mi Shao, MD1*, Linghui Zhou, MD2*, Guoqing Wei, MD3*, Wenjun Wu, MD1*, Alex Hong Chang, MD4*, Tao Sun, Phd5,6*, Yongxian HU, MD7* and He Huang8

1Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, CHN
3Bone Marrow Transplantation Center, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
4Shanghai YaKe Biotechnology Ltd, Shanghai, China
5Genetron Health (Beijing) Co., Ltd, Beijing, China
6Hangzhou ImmuQuad Biotechnologies, LLC, Hangzhou, China
7Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, AL, China
8Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Kitsada Wudhikarn, MD1, Ana Alarcon Tomas2*, Jamie Brower, MS3*, Veronika Bachanova, MD, PhD4, Richard T. Maziarz, MD5, Joseph P. McGuirk, DO6, Loretta Nastoupil, MD7, David L. Porter, MD8*, Peter A. Riedell, MD9 and Miguel-Angel Perales, MD10

1Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
2Memorial Sloan Kettering Cancer Center, New York, NY
3Division of Hematology-Oncology/Department of Medicine, University of Pennsylvania, Philadelphia, PA
4Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN
5Knight Cancer Institute, Oregon Health and Science University, Portland, OR
6Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
7Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
8Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
9Department of Medicine, The University of Chicago Medicine, Chicago, IL
10Department of Medicine, Adult Bone Marrow Transplantation, Memorial Sloan Kettering Cancer Center, New York, NY

Bernhard Gentner, MD1,2, Gaetano Finocchiaro, MD3*, Francesca Farina, MD4*, Marica Eoli, MD5*, Capotondo Alessia, PhD6*, Elena Anghileri, MD7*, Gabriele Antonarelli, MD8,9*, Matteo Barcella, PhD10*, Maria Grazia Bruzzone, MD11*, Matteo Giovanni Carrabba12*, Valeria Cuccarini, MD11*, Giorgio D'Alessandris, MD13*, Francesco Di Meco, MD14*, Valeria Ferla, MD8*, Paolo Ferroli, MD14*, Filippo Gagliardi, MD15*, Mariagrazia Garramone6*, Federico Legnani, MD14*, Pietro Mortini, MD16*, Matteo Maria Naldini, MD17*, Alessandro Olivi, MD13*, Roberto Pallini, MD13*, Monica Patanè18*, Rosina Paterra5*, Bianca Pollo, MD18*, Marco Saini, MD14*, Silvia Snider, MD16*, Valentina Brambilla19*, Tiziana Magnani19*, Stefania Mazzoleni19*, Zahid Bashir, MD19*, Carlo Russo, MD20*, Luigi Naldini, MD, PhD10,21* and Fabio Ciceri21,22*

1Translational Stem Cell and Leukemia Research Unit, San Raffale Scientific Institute, Milano, Italy
2Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Hospital, Milano, Italy
3Neuro-Oncology Unit, IRCSS San Raffaele Hospital, Milan, Italy
4Hematology and Bone Marrow Transplant Unit, IRCCS San Raffaele Hospital, Milano, ITA
5Neuro-Oncology Unit, Istituto Neurologico Carlo Besta, Milan, Italy
6SR-Tiget Clinical Lab, San Raffaele Telethon Institute for Gene Therapy, Milan, Italy
7Neuro-Oncology Unit, IRCCS Istituto Neurologico Carlo Besta, Milano, Italy
8Hematology and Bone Marrow Transplant Unit, IRCSS San Raffaele Hospital, Milan, Italy
9Translational stem cell and leukemia research Unit, SR-TIGET, San Raffaele Telethon Institute for Gene Therapy, Milan, Italy
10San Raffaele Telethon Institute for Gene Therapy, Milan, Italy
11Neuroradiology Unit, Istituto Neurologico Carlo Besta, Milan, Italy
12Hematology and Bone Marrow Transplant Unit, IRCCS San Raffaele Hospital, Milan, Italy
13Neurosurgery Unit, Policlinico Gemelli, Rome, Italy
14Neurosurgery Unit, Istituto Neurologico Carlo Besta, Milan, Italy
15Neurosurgery unit, IRCCS San Raffaele Hospital, Milano, Italy
16Neurosurgery Unit, IRCSS San Raffaele Hospital, Milan, Italy
17Translational stem cell and leukemia research Unit, San Raffaele Telethon Institute for Gene Therapy, Milan, Italy
18Neuropathology Unit, Istituto Neurologico Carlo Besta, Milan, Italy
19Genenta Science, Milan, Italy
20Genenta Science, New York
21Vita-Salute San Raffaele University, Milan, Italy
22Haematology and Bone Marrow Transplant Unit, IRCCS San Raffaele Scientific Hospital, Milan, Italy

Xin Li1*, Qian Cheng1*, Rui Liu1*, Liqing Kang2*, Nan Xu2,3*, Minghao Li2,3* and Lei Yu2,3*

1Department of Hematology, The Third Xiangya Hospital of Central South University, Changsha, China
2Shanghai Unicar-Therapy Bio-medicine Technology Co., Ltd, Shanghai, China
3Institute of Biomedical Engineering and Technology, Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China

*signifies non-member of ASH